Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease

被引:12
|
作者
Alongi, Filippo [1 ,5 ]
Arcangeli, Stefano [2 ]
Triggiani, Luca [3 ]
Mazzola, Rosario [1 ]
di Monale e Bastia, Michela Buglione [3 ]
Fersino, Sergio [1 ]
Baiguini, Anna [3 ]
Jereczek-Fossa, Barbara Alicja [4 ]
Magrini, Stefano Maria [3 ]
机构
[1] Sacro Cuore Don Calabria Canc Care Ctr, Radiat Oncol, Negrar Verona, Italy
[2] San Camillo & Forlanini Hosp, Radiat Oncol, Rome, Italy
[3] Spedali Civili Brescia, Radiat Oncol, Brescia, Italy
[4] Univ Milan, European Inst Oncol, Radiat Oncol, Milan, Italy
[5] Univ Brescia, Brescia, Italy
关键词
Stereotactic radiotherapy; SABR; Renal cell carcinoma; Oligometastases; INITIAL CLINICAL-EXPERIENCE; DOSE-PER-FRACTION; BODY RADIOTHERAPY; SPINAL METASTASES; FOLLOW-UP; RADIOSURGERY; CANCER; IMMUNOTHERAPY; NEPHRECTOMY; KIDNEY;
D O I
10.1016/j.critrevonc.2017.07.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Renal Cell Carcinoma (RCC) has historically been considered a radioresistant cancer, and radiotherapy was usually delivered with a palliative goal. Stereotactic ablative radiotherapy (SABR) allows the delivery of high doses on small treatment volumes in a safe and effective way, thus opening the doors to new applicationsof radiotherapy both in the treatment of the primary and oligometastasic disease. Aim of the current review is to explore the state of art of SABR in the therapeutic approach to RCC. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:48 / 56
页数:9
相关论文
共 50 条
  • [1] Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma
    Schoenhals, Jonathan E.
    Mohamad, Osama
    Christie, Alana
    Zhang, Yuanyuan
    Li, Daniel
    Singla, Nirmish
    Bowman, Isaac
    Arafat, Waddah
    Hammers, Hans
    Courtney, Kevin
    Cole, Suzanne
    Bagrodia, Aditya
    Margulis, Vitaly
    Desai, Neil
    Garant, Aurelie
    Choy, Hak
    Timmerman, Robert
    Brugarolas, James
    Hannan, Raquibul
    ADVANCES IN RADIATION ONCOLOGY, 2021, 6 (05)
  • [2] Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies
    Zaorsky, Nicholas G.
    Lehrer, Eric J.
    Kothari, Gargi
    Louie, Alexander, V
    Siva, Shankar
    EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (05): : 515 - 523
  • [3] Stereotactic Ablative Radiation Therapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer
    Zhang, Yuanyuan
    Schoenhals, Jonathan
    Christie, Alana
    Mohamad, Osama
    Wang, Chiachien
    Bowman, Isaac
    Singla, Nirmish
    Hammers, Hans
    Courtney, Kevin
    Bagrodia, Aditya
    Margulis, Vitaly
    Desai, Neil
    Garant, Aurelie
    Choy, Hak
    Timmerman, Robert
    Brugarolas, James
    Hannan, Raquibul
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (02): : 367 - 375
  • [4] Role of Stereotactic Body Radiation Therapy for the Management of Oligometastatic Renal Cell Carcinoma
    Franzese, Ciro
    Franceschini, Davide
    Di Brina, Lucia
    D'Agostino, Giuseppe Roberto
    Navarria, Pierina
    Comito, Tiziana
    Mancosu, Pietro
    Tomatis, Stefano
    Scorsetti, Marta
    JOURNAL OF UROLOGY, 2019, 201 (01): : 70 - 75
  • [5] The role of stereotactic ablative body radiotherapy in renal cell carcinoma: focus on oligometastatic and oligoprogressive disease
    Marandino, Laura
    Ciccarese, Chiara
    Francolini, Giulio
    Amparore, Daniele
    Campi, Riccardo
    MINERVA UROLOGY AND NEPHROLOGY, 2023, 75 (02): : 260 - 264
  • [6] Stereotactic ablative body radiation for oligometastatic and oligoprogressive disease
    Ning, Matthew S.
    Gomez, Daniel R.
    Heymach, John V.
    Swisher, Stephen G.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (01) : 97 - 106
  • [7] Circulating tumor DNA in the surveillance of patients with oligometastatic renal cell carcinoma treated with stereotactic ablative radiation.
    Pop, Laurentiu
    Stein, Maggie Janell
    Christie, Alana
    Manna, Subrata
    Garant, Aurelie
    Yang, Daniel X.
    Desai, Neil B.
    Brugarolas, James
    Timmerman, Robert D.
    Hannan, Raquibul
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 477 - 477
  • [8] Stereotactic Ablative Radiotherapy for the Treatment of Clinically Localized Renal Cell Carcinoma
    Campbell, Scott P.
    Song, Daniel Y.
    Pierorazio, PhillipM.
    Allaf, Mohamad E.
    Gorin, Michael A.
    JOURNAL OF ONCOLOGY, 2015, 2015
  • [9] Stereotactic Ablative Radiation Therapy for the Treatment of Oligometastatic Prostate Cancer
    Tran, P. T.
    Radwan, N.
    Ross, A. E.
    Reyes, D.
    Wright, J. L.
    Song, D.
    Deville, C., Jr.
    DeWeese, T. L.
    Carducci, M.
    Schaeffer, E. M.
    Pienta, K.
    Eisenberger, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E248 - E248
  • [10] Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases
    Wang, Chiachien Jake
    Christie, Alana
    Lin, Mu-Han
    Jung, Matthew
    Weix, Derek
    Huelsmann, Lorel
    Kuhn, Kristin
    Meyer, Jeffrey
    Desai, Neil
    Kim, D. W. Nathan
    Pedrosa, Ivan
    Margulis, Vitaly
    Cadeddu, Jeffrey
    Sagalowsky, Arthur
    Gahan, Jeffrey
    Laine, Aaron
    Xie, Xian-Jin
    Choy, Hak
    Brugarolas, James
    Timmerman, Robert
    Hannan, Raquibul
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (01): : 91 - 100